Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × INDUSTRY × R-CHOP protocol × Clear all

Phase

Status

Active not recruiting 4 Unknown 2 Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Paclitaxel 31 Cyclophosphamide 30 Cisplatin 29 Carboplatin 27 Bevacizumab 27 Fluorouracil 24 pembrolizumab 21 Nivolumab 21 Leucovorin 20 Rituximab 19 avelumab 18 Gemcitabine 18 Docetaxel 18 Dexamethasone 18 Capecitabine 17 130-nm albumin-bound paclitaxel 14 ALT-803 13 Oxaliplatin 12 Cetuximab 12 fludarabine 11 Ipilimumab 11 venetoclax 10 atezolizumab 10 Radiosurgery 10 Radiotherapy 9 Pemetrexed 9 Omacor 9 Lenalidomide 9 Bendamustine Hydrochloride 9 yeast-CEA vaccine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02605694 2021-03-17

FRESCO

SecuraBio

Phase 2 Withdrawn

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡